Replies to post #16091 on Nascent Pharma Holdings Inc (NASC)

[sleekscape]

CANB has your favorite chart + massive revenue growth in Q4 + small float + following in path of other CBD Oil mega-movers like POTN and CVSI in 2018 and EDXC In 2019

So the fundamentals and float are there as well, and the roadmap to being a CBD Oil star on the OTC is clear — demonstrate massive revenue growth

Really looking forward to seeing the Q1 report


Sleek